Skip Navigation
Skip to contents

Intest Res : Intestinal Research

IMPACT FACTOR

Search

Page Path
HOME > Search
6 "Therapeutics"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Reviews
IBD
Treatment of primary sclerosing cholangitis combined with inflammatory bowel disease
You Sun Kim, Edward H. Hurley, Yoojeong Park, Sungjin Ko
Intest Res 2023;21(4):420-432.   Published online September 1, 2023
DOI: https://doi.org/10.5217/ir.2023.00039
AbstractAbstract PDFPubReaderePub
Primary sclerosing cholangitis (PSC) is a progressive cholestatic, inflammatory, and fibrotic disease that is strongly associated with inflammatory bowel disease (IBD). PSC-IBD represents a unique disease entity and patients with this disease have an increased risk of malignancy development, such as colorectal cancer and cholangiocarcinoma. The pathogenesis of PSC-IBD involves genetic and environmental factors such as gut dysbiosis and bile acids alteration. However, despite the advancement of disease characteristics, no effective medical therapy has proven to have a significant impact on the prognosis of PSC. The treatment options for patients with PSC-IBD do not differ from those for patients with PSC alone. Potential candidate drugs have been developed based on the pathogenesis of PSC-IBD, such as those that target modulation of bile acids, inflammation, fibrosis, and gut dysbiosis. In this review, we summarize the current medical treatments for PSC-IBD and the status of new emerging therapeutic agents.

Citations

Citations to this article as recorded by  
  • Hepatic Nuclear Receptors in Cholestasis-to-Cholangiocarcinoma Pathology
    Inyoung Cheon, Minwook Kim, Kang Ho Kim, Sungjin Ko
    The American Journal of Pathology.2025; 195(3): 409.     CrossRef
  • Documento de posicionamiento de la Sociedad Española de Médicos de Atención Primaria (SEMERGEN) y del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) sobre el manejo de la enfermedad inflamatoria intestinal en atención primari
    Daniel Ginard, Noelia Fontanillas, Iria Bastón-Rey, M. Elena Pejenaute, Marta Piqueras, Silvia Alcalde, Pilar Nos, Mercedes Ricote, Lucía Expósito, Míriam Mañosa, Manuel Barreiro-de Acosta, Francisco Rodríguez-Moranta, Yamile Zabana, José Polo, Ana Gutiér
    Gastroenterología y Hepatología.2025; 48(3): 502255.     CrossRef
  • Documento de posicionamiento de la Sociedad Española de Médicos de Atención Primaria (SEMERGEN) y del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) sobre el manejo de la enfermedad inflamatoria intestinal en atención primari
    Daniel Ginard, Noelia Fontanillas, Iria Bastón-Rey, M. Elena Pejenaute, Marta Piqueras, Silvia Alcalde, Pilar Nos, Mercedes Ricote, Lucía Expósito, Míriam Mañosa, Manuel Barreiro-de Acosta, Francisco Rodríguez-Moranta, Yamile Zabana, José Polo, Ana Gutiér
    Medicina de Familia. SEMERGEN.2025; 51(3): 102334.     CrossRef
  • Position statement of the Spanish Society of Primary Care Physicians (SEMERGEN) and Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the management of inflammatory bowel disease in Primary Care
    Daniel Ginard, Noelia Fontanillas, Iria Bastón-Rey, M. Elena Pejenaute, Marta Piqueras, Silvia Alcalde, Pilar Nos, Mercedes Ricote, Lucía Expósito, Míriam Mañosa, Manuel Barreiro-de Acosta, Francisco Rodríguez-Moranta, Yamile Zabana, José Polo, Ana Gutiér
    Gastroenterología y Hepatología (English Edition).2025; 48(3): 502255.     CrossRef
  • Novel preclinical developments of the primary sclerosing cholangitis treatment landscape
    Aalam Sohal, Kris V. Kowdley
    Expert Opinion on Investigational Drugs.2024; 33(4): 335.     CrossRef
  • Gut Microbiota in Primary Sclerosing Cholangitis: From Prognostic Role to Therapeutic Implications
    Valeria Maccauro, Francesca Fianchi, Antonio Gasbarrini, Francesca Romana Ponziani
    Digestive Diseases.2024; 42(4): 369.     CrossRef
  • Global research trends on the relationship between IBD and CRC: a bibliometric analysis from 2000 to 2023
    Hao Zhang, Huiru Xin, Mengqi Zhao, Chenyang Bi, Yafei Xiao, Yifan Li, Changjiang Qin
    Journal of Health, Population and Nutrition.2024;[Epub]     CrossRef
  • Halitosis: an underestimated but important extraintestinal manifestation in inflammatory bowel disease
    Xiao Xian Qian
    Intestinal Research.2024; 22(3): 387.     CrossRef
  • Phenotypes of primary sclerosing cholangitis in children
    M.B. Dyba, V.S. Berezenko
    GASTROENTEROLOGY.2024; 58(4): 270.     CrossRef
  • 6,115 View
  • 630 Download
  • 10 Web of Science
  • 9 Crossref
Close layer
Cancer
Endoscopic diagnosis and treatment of early colorectal cancer
Seung Wook Hong, Jeong-Sik Byeon
Intest Res 2022;20(3):281-290.   Published online July 26, 2022
DOI: https://doi.org/10.5217/ir.2021.00169
AbstractAbstract PDFPubReaderePub
Early colorectal cancer refers to cancer in the colorectum that is confined to the mucosa or submucosa and does not invade the muscularis propria, irrespective of lymph node or distant metastasis. As the number of persons undergoing screening colonoscopy increases, the proportion of patients diagnosed with precancerous colorectal lesions and early colorectal cancer also increases. In the last decade, innovative optical technologies for endoscopic diagnosis have been introduced and endoscopic treatment techniques such as endoscopic submucosal dissection have provided major breakthroughs in the management of early colorectal cancer. With these remarkable developments, endoscopic treatment has established itself as an alternative to surgical resection in the treatment of early colorectal cancer. This review will discuss the endoscopic diagnosis and treatment of early colorectal cancer. Furthermore, the unmet needs in this field and the latest research addressing those issues will be summarized.

Citations

Citations to this article as recorded by  
  • Artificial Intelligence Models May Aid in Predicting Lymph Node Metastasis in Patients with T1 Colorectal Cancer
    Ji Eun Baek, Hahn Yi, Seung Wook Hong, Subin Song, Ji Young Lee, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Byong Duk Ye, Seung-Jae Myung, Suk-Kyun Yang, Namkug Kim, Jeong-Sik Byeon
    Gut and Liver.2025; 19(1): 69.     CrossRef
  • Cost-effectiveness analysis of sequential two-step screening versus direct colonoscopy screening for colorectal cancer: a large-scale survey in Eastern China
    Yun Fu, Hao Li, Ao Xu, Zhongrong Yang, Peng Zhang, Weibing Wang
    Frontiers in Oncology.2025;[Epub]     CrossRef
  • Advancements in the application of artificial intelligence in the field of colorectal cancer
    Mengying Zhu, Zhenzhu Zhai, Yue Wang, Fang Chen, Ruibin Liu, Xiaoquan Yang, Guohua Zhao
    Frontiers in Oncology.2025;[Epub]     CrossRef
  • Case report: Successful treatment of advanced colon cancer in an eighty-year-old man with long-term and multi-stage endoscopic minimally invasive therapy
    Nana Zhang, Lulu Zhu, Yan Liu, Xiaolong Chen, Bifang Zhang, Chunhong Wen, Huayu Zhang, Qinglin Tang, Mingqing Zhang
    Frontiers in Oncology.2024;[Epub]     CrossRef
  • Prediction of Lymph Node Metastasis in T1 Colorectal Cancer Using Artificial Intelligence with Hematoxylin and Eosin-Stained Whole-Slide-Images of Endoscopic and Surgical Resection Specimens
    Joo Hye Song, Eun Ran Kim, Yiyu Hong, Insuk Sohn, Soomin Ahn, Seok-Hyung Kim, Kee-Taek Jang
    Cancers.2024; 16(10): 1900.     CrossRef
  • Influence of Certification Program on Treatment Quality and Survival for Rectal Cancer Patients in Germany: Results of 13 Certified Centers in Collaboration with AN Institute
    Mihailo Andric, Jessica Stockheim, Mirhasan Rahimli, Sara Al-Madhi, Sara Acciuffi, Maximilian Dölling, Roland Siegfried Croner, Aristotelis Perrakis
    Cancers.2024; 16(8): 1496.     CrossRef
  • Screening and surveillance for hereditary colorectal cancer
    Hee Man Kim, Tae Il Kim
    Intestinal Research.2024; 22(2): 119.     CrossRef
  • The Usefulness of Vitamin K-Dependent Proteins in the Diagnosis of Colorectal Carcinoma
    Mirela-Georgiana Perné, Adela-Viviana Sitar-Tăut, Olga Hilda Orășan, Vasile Negrean, Călin Vasile Vlad, Teodora-Gabriela Alexescu, Mircea Vasile Milaciu, Lorena Ciumărnean, Răzvan Dan Togănel, Gabriel Emil Petre, Ioan Șimon, Alexandra Crăciun
    International Journal of Molecular Sciences.2024; 25(9): 4997.     CrossRef
  • Strategies to improve screening colonoscopy quality for the prevention of colorectal cancer
    Joo Hye Song, Eun Ran Kim
    The Korean Journal of Internal Medicine.2024; 39(4): 547.     CrossRef
  • Patient and procedural factors associated with true histology rates in patients undergoing colonoscopy with computer-aided detection of polyps
    Aasma Shaukat, David R. Lichtenstein, Daniel C. Chung, Caitlyn Seidl, Yeli Wang, Emma E. Navajas, Daniel R. Colucci, Shrujal Baxi, William R. Brugge
    Gastrointestinal Endoscopy.2024; 100(6): 1090.     CrossRef
  • Short‐term morbidity and mortality after right hemicolectomy: an update of national performance in the Netherlands
    J. M. L. Sijmons, A. A. J. Grüter, B. R. Toorenvliet, R. A. E. M. Tollenaar, J. W. T. Dekker, P. J. Tanis, J. B. Tuynman
    Colorectal Disease.2024; 26(11): 1983.     CrossRef
  • Efficacy of Oral Sulfate Tablet and 2 L-Polyethylene Glycol With Ascorbic Acid for Bowel Preparation: A Prospective Randomized KASID Multicenter Trial
    Yunho Jung, Hyun Gun Kim, Dong-Hoon Yang, Hyoun Woo Kang, Jae Jun Park, Dong Hoon Baek, Jaeyoung Chun, Tae-Geun Gweon, Hyeon Jeong Goong, Min Seob Kwak, Hyun Jung Lee, Soo-Kyung Park, Jong Hoon Lee
    Journal of Korean Medical Science.2024;[Epub]     CrossRef
  • Olfactomedin 4 produces dysplasia but suppresses metastasis of colon cancer
    Hyun Woo Ma, Jung Min Kim, Da Hye Kim, I Seul Park, Ji Hyung Kim, Ki Cheong Park, Dong Hyuk Seo, Jae Hyeon Kim, Xiumei Che, Tae Il Kim, Jae Hee Cheon, Seung Won Kim
    Cancer Gene Therapy.2023; 30(5): 694.     CrossRef
  • Past, present, and future of Intestinal Research
    Jae Hee Cheon
    Intestinal Research.2023; 21(1): 1.     CrossRef
  • Chasm between Public Perceptions and Epidemiological Data on Colorectal Cancer
    Su Bee Park, Min Seob Kwak, Jin Young Yoon, Jae Myung Cha
    Gut and Liver.2023; 17(3): 449.     CrossRef
  • Technique, sedation, and clinical outcome of endoscopic submucosal dissection for rectal tumor with involvement of dentate line: A retrospective cohort study
    Yoon Kyoo Noh, Jun Lee, Seong Jung Kim
    Saudi Journal of Gastroenterology.2023; 29(6): 365.     CrossRef
  • Նորագույն էնդոսկոպիկ մեթոդների դերը հաստ աղու նորագոյացությունների ախտորոշման և բուժման մեջ
    Ն. Գ. Զալինյան, Ա. Մ. Խալաթյան, Ս. Ա. Խաչատրյան, Մ. Ա. Նալբանդյան, Տ. Է. Ստեփանյան, Գ. Ն. Թամամյան, Կ. Դ. Մանուկյան
    Medical Science of Armenia.2023; : 11.     CrossRef
  • Effectiveness and Safety of Endoscopic Submucosal Dissection for Colorectal Neoplasm in Patients with High Charlson Comorbidity Index Score: A HASID Multicenter Study
    Dong-Hyun Kim, Yong-Wook Jung, Byung-Chul Jin, Hyung-Hoon Oh, Hyo-Yeop Song, Seong-Jung Kim, Dae-Seong Myung, Sang-Wook Kim, Jun Lee, Geom-Seog Seo, Young-Eun Joo, Hyun-Soo Kim
    Journal of Clinical Medicine.2023; 12(19): 6255.     CrossRef
  • The tumor suppressive effect and apoptotic mechanism of TRAIL gene‐containing recombinant NDV in TRAIL‐resistant colorectal cancer HT‐29 cells and TRAIL‐nonresistant HCT116 cells, with each cell bearing a mouse model
    Bo‐Kyoung Jung, Yong Hee An, Sung Hoon Jang, Gyoungah Ryu, Saet‐byel Jung, Seonhee Kim, Cuk‐Seong Kim, Hyun Jang
    Cancer Medicine.2023; 12(20): 20380.     CrossRef
  • Clinical characteristics and risk factors related to polyposis recurrence and advanced neoplasm development among patients with non-hereditary colorectal polyposis
    Jihun Jang, Jihye Park, Soo Jung Park, Jae Jun Park, Jae Hee Cheon, Tae Il Kim
    Intestinal Research.2023; 21(4): 510.     CrossRef
  • Summary and comparison of recently updated post-polypectomy surveillance guidelines
    Yoon Suk Jung
    Intestinal Research.2023; 21(4): 443.     CrossRef
  • Wide-field endoscope accessory for multiplexed fluorescence imaging
    Gaoming Li, Miki Lee, Tse-Shao Chang, Joonyoung Yu, Haijun Li, Xiyu Duan, Xiaoli Wu, Sangeeta Jaiswal, Shuo Feng, Kenn R. Oldham, Thomas D. Wang
    Scientific Reports.2023;[Epub]     CrossRef
  • Endoscopic characterization of neoplastic and non-neoplastic lesions in inflammatory bowel disease: systematic review in the era of advanced endoscopic imaging
    Andrea Cassinotti, Marco Parravicini, Thomas P. Chapman, Marco Balzarini, Lorenzo Canova, Simone Segato, Valentina Zadro, Simon Travis, Sergio Segato
    Therapeutic Advances in Gastroenterology.2023;[Epub]     CrossRef
  • Prediction of disease recurrence or residual disease after primary endoscopic resection of pT1 colorectal cancer—results from a large nationwide Danish study
    Ilze Ose, Katarina Levic, Lau Caspar Thygesen, Orhan Bulut, Thue Bisgaard, Ismail Gögenur, Tine Plato Kuhlmann
    International Journal of Colorectal Disease.2023;[Epub]     CrossRef
  • 5,789 View
  • 292 Download
  • 23 Web of Science
  • 24 Crossref
Close layer
Original Article
IBD
Clinical features of very early-onset inflammatory bowel disease in Japan: a retrospective single-center study
Masaaki Usami, Ichiro Takeuchi, Reiko Kyodo, Yuri Hirano, Kosuke Kashiwagi, Hiroki Fujikawa, Hirotaka Shimizu, Toshinao Kawai, Katsuhiro Arai
Intest Res 2022;20(4):475-481.   Published online June 13, 2022
DOI: https://doi.org/10.5217/ir.2021.00142
AbstractAbstract PDFPubReaderePub
Background/Aims
Very early-onset inflammatory bowel disease (VEO-IBD), defined as IBD diagnosed in patients younger than 6 years, is a challenge for pediatric gastroenterologists. Although there have been reports regarding VEO-IBD in Western countries, those in Asia are still lacking. This study aimed to investigate the clinical features of Japanese VEO-IBD patients.
Methods
Patients with VEO-IBD diagnosed between 2006 and 2019 were evaluated retrospectively. The disease phenotypes were classified into ulcerative colitis type (UC-type) and Crohn’s disease type (CD-type), and the clinical features and courses were compared between the phenotypes.
Results
Overall, 54 VEO-IBD patients (19 patients with UC-type and 35 patients with CD-type) were evaluated. The median age at onset was 18 months. One patient had severe combined immunodeficiency (SCID), and 9 patients had monogenic IBD. Monogenic IBD was more prevalent in the CD-type patients with perianal disease (CD-type (PD)). The age at onset was significantly lower in the CD-type group (P<0.05). The most common initial symptom was bloody stools (70%), followed by diarrhea (63%), weight loss (24%), fever (20%), and perianal disease (20%). Excluding patients with SCID and monogenic IBD, 23 out of 44 patients (52%) required biologics. The biologics were switched in 11 out of 44 patients (25%), and the majority of these patients (82%) were in the CD-type group. Overall, 9 patients (20%) required intestinal resection or ostomy placement.
Conclusions
CD-type tends to occur at an earlier age, and monogenic IBD occurs significantly more frequently in CD-type (PD). Disease severity and treatment should be individualized, owing to the disease heterogeneity.

Citations

Citations to this article as recorded by  
  • Long‐term clinical and endoscopic outcomes of ustekinumab in pediatric Crohn's disease with anti‐tumor necrosis factor failure
    Yoko Yamamoto, Ichiro Takeuchi, Hirotaka Shimizu, Hiroki Fujikawa, Masanori Toda, Eri Miyata, Hiroaki To, Satoru Nagata, Katsuhiro Arai
    Journal of Gastroenterology and Hepatology.2025; 40(1): 123.     CrossRef
  • Disease phenotypic and outcome of very-early onset inflammatory bowel disease in Asian children: an understudied population
    Way-Seah Lee, Kee-Seang Chew, James-Guoxian Huang, Pornthep Tanpowpong, Karen S. C. Mercado, Almida Reodica, Veena Logarajah, K. L. W. Hathagoda, Shaman Rajindrajith, Yoko Kin-Yoke Wong, Suporn Treepongkaruna, Marion Margaret Aw
    Frontiers in Pediatrics.2025;[Epub]     CrossRef
  • Impact of age at diagnosis on long‐term prognosis in patients with intestinal Behçet's disease
    Ji Young Chang, Soo Jung Park, Jae Jun Park, Tae Il Kim, Jae Hee Cheon, Jihye Park
    Journal of Gastroenterology and Hepatology.2024; 39(3): 519.     CrossRef
  • Neither hepatic steatosis nor fibrosis is associated with clinical outcomes in patients with intestinal Behçet’s disease
    Hye Kyung Hyun, Jihye Park, Soo Jung Park, Jae Jun Park, Tae Il Kim, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim, Jae Hee Cheon
    European Journal of Gastroenterology & Hepatology.2024; 36(4): 445.     CrossRef
  • Surgical outcomes of very-early-onset ulcerative colitis: retrospective comparative study with older pediatric patients
    Takashi Fumita, Keita Terui, Ryohei Shibata, Ayako Takenouchi, Shugo Komatsu, Satoru Oita, Hiroko Yoshizawa, Yuichi Hirano, Yusaku Yoshino, Takeshi Saito, Tomoro Hishiki
    Pediatric Surgery International.2024;[Epub]     CrossRef
  • Fecal Calprotectin at Postinduction Is Capable of Predicting Persistent Remission and Endoscopic Healing after 1 Year of Treatment with Infliximab in Pediatric Patients with Crohn’s Disease
    Yoo Min Lee, Eun Sil Kim, Sujin Choi, Hyo-Jeong Jang, Yu Bin Kim, So Yoon Choi, Byung-Ho Choe, Ben Kang
    Gut and Liver.2024; 18(3): 498.     CrossRef
  • Genomic testing identifies monogenic causes in patients with very early-onset inflammatory bowel disease: a multicenter survey in an Iranian cohort
    Golnaz Eslamian, Mahnaz Jamee, Tooba Momen, Pejman Rohani, Sarehossadat Ebrahimi, Mehrnaz Mesdaghi, Soodeh Ghadimi, Mahboubeh Mansouri, Seyed Alireza Mahdaviani, Mahnaz Sadeghi-shabestari, Morteza Fallahpour, Bibi Shahin Shamsian, Narges Eslami, Samin Sha
    Clinical and Experimental Immunology.2024; 217(1): 1.     CrossRef
  • 4,374 View
  • 391 Download
  • 8 Web of Science
  • 7 Crossref
Close layer
Reviews
IBD
The impact of tobacco smoking on treatment choice and efficacy in inflammatory bowel disease
Steven Nicolaides, Abhinav Vasudevan, Tony Long, Daniel van Langenberg
Intest Res 2021;19(2):158-170.   Published online October 13, 2020
DOI: https://doi.org/10.5217/ir.2020.00008
AbstractAbstract PDFPubReaderePub
Smoking significantly increases the risk of developing and worsens Crohn’s disease (CD), yet protects against the development and reduces the severity of ulcerative colitis. It is less clear whether smoking impacts the efficacy of therapeutics in inflammatory bowel disease (IBD). We review the literature regarding the relationship between smoking and the efficacy of medical and surgical therapy in IBD. Smoking is associated with alterations in thiopurine metabolism and may affect time to disease relapse. The outcomes of anti-tumor necrosis factor therapy in active smokers appear neutral with data lacking for newer biologics. Smoking increases the risk of postoperative recurrence in those requiring resection for CD, likely attributable to perturbations of the gut microbiota although further implications of these for disease onset/progression and treatment efficacy remain unclear. Multiple lifestyle and psychosocial confounders are likely under-recognized cofactors in the association between smoking and IBD. Despite the widely promulgated risks associated with cigarette smoking in CD, more incisive data are required to further elucidate the actual relationship between smoking and disease pathways, while accounting for the several negative cofactors prevalent in smokers which cast uncertainty on the magnitude of the direct effect of smoking on disease pathophysiology and the efficacy of therapy.

Citations

Citations to this article as recorded by  
  • DAMP-ing IBD: Extinguish the Fire and Prevent Smoldering
    Oliver Sandys, Pieter C. F. Stokkers, Anje A. te Velde
    Digestive Diseases and Sciences.2025; 70(1): 49.     CrossRef
  • The Effects of Combustible Cigarettes and Electronic Nicotine Delivery Systems on Immune Cell-Driven Inflammation and Mucosal Healing in Ulcerative Colitis
    Nikolina Kastratovic, Vladimir Markovic, Aleksandar Arsenijevic, Ana Volarevic, Natasa Zdravkovic, Marija Zdravkovic, Marija Brankovic, Tijana Gmizic, Carl Randall Harrell, Vladimir Jakovljevic, Valentin Djonov, Vladislav Volarevic
    Nicotine and Tobacco Research.2025; 27(3): 542.     CrossRef
  • Smoking Experience before Adulthood Is Associated with an Increased Risk of Developing Ulcerative Colitis in Adult Ex-Smokers
    Yu Kyung Jun, Bongseong Kim, Yonghoon Choi, Cheol Min Shin, Young Soo Park, Nayoung Kim, Dong Ho Lee, Kyungdo Han, Hyuk Yoon
    Yonsei Medical Journal.2025; 66(1): 9.     CrossRef
  • Recurrence rates after strictureplasty for small bowel Crohn's disease remain high in the era of biologics
    A. Nasasra, T. E. M. Morrison, A. Luberto, M. Carvello, K. J. Williams, J. Davies, A. Spinelli, A. M. Mehta, J. H. Warusavitarne
    Colorectal Disease.2025;[Epub]     CrossRef
  • The Importance of Nutriepigenetics in Older Adults with Inflammatory Bowel Disease
    Ana-Gabriela Prada, Costina Daniela Gîță, Sandra Monica Gîdei, Doina Istratescu, Tudor Stroie, Sorina Maria Aurelian, Gabriel Ioan Prada, Ovidiu Nicolae Penes, Anca Lucia Pop, Mihai Mircea Diculescu
    Nutrients.2025; 17(4): 620.     CrossRef
  • Defining the Roles of Inflammatory Bowel Disease Clinical Pharmacists in the United States: A Systematic Review and National RAND/UCLA Consensus
    Shubha Bhat, Ruishen Lyu, Mitali Agarwal, Michelle Becker, Richard Bloomfeld, David H Bruining, Benjamin L Cohen, Marina Ivanov, Jonathan A Leighton, Alyssa P Stewart, Lindsay Trocke, Stacy S Tse, Ryan C Ungaro, Byron P Vaughn, Miguel Regueiro, Erick Sokn
    Inflammatory Bowel Diseases.2024; 30(6): 950.     CrossRef
  • Duration of smoking cessation in patients with inflammatory bowel disease
    Carlos González-Muñoza, Cristina Gely, Jordi Gordillo, Federico Bertoletti, Antonio Giordano, Alberto López-Faba, Esther García-Planella
    Gastroenterología y Hepatología.2024; 47(6): 591.     CrossRef
  • Role of Environmental Risk Factors in the Etiology of Inflammatory Bowel Diseases: A Multicenter Study
    Cemile Cansu Alperen, Barıs Soydas, Ender Serin, Mustafa Erbayrak, Nurten Akyurek Savas, Gulhan Kanat Unler, Cenk Emre Meral, Ugur Toprak, Ahmet Sedat Boyacioglu, Ulku Dagli
    Digestive Diseases and Sciences.2024; 69(8): 2927.     CrossRef
  • Need for therapeutic escalation in patients with refractory ulcerative proctitis: Results from the PROCU study of the ENEIDA registry
    Rocío Ferreiro‐Iglesias, Sol Porto Silva, Sandra Marín, María José Casanova, Míriam Mañosa, Carlos González‐Muñoza, Ruth de Francisco, Berta Caballol, Lara Arias, Marta Piqueras, Yamile Zabana, Montserrat Rivero, Xavier Calvet, Francisco Mesonero, Pilar V
    Alimentary Pharmacology & Therapeutics.2024; 60(5): 604.     CrossRef
  • Akkermansia muciniphila and Parabacteroides distasonis as prognostic markers for relapse in ulcerative colitis patients
    Ana Mendes-Frias, Marta Moreira, Maria C. Vieira, Joana Gaifem, Patrício Costa, Luís Lopes, Ricardo Silvestre
    Frontiers in Cellular and Infection Microbiology.2024;[Epub]     CrossRef
  • Duration of smoking cessation in patients with inflammatory bowel disease
    Carlos González-Muñoza, Cristina Gely, Jordi Gordillo, Federico Bertoletti, Antonio Giordano, Alberto López-Faba, Esther García-Planella
    Gastroenterología y Hepatología (English Edition).2024; 47(6): 591.     CrossRef
  • Clinical Outcomes After First-Line Anti- Tumor-Necrosis-Factor Treatment of Patients With Inflammatory Bowel Disease—A Prospective Multicenter Cohort Study
    Mirabella Zhao, Lone Larsen, Anders Dige, Anja Poulsen, Bobby Lo, Mohamed Attauabi, Pernille Dige Ovesen, Mads Damsgaard Wewer, Dagmar Christiansen, Christian Lodberg Hvas, Andreas Munk Petersen, Flemming Bendtsen, Jakob Seidelin, Johan Burisch
    Journal of Crohn's and Colitis.2024;[Epub]     CrossRef
  • Tobacco use in Crohn's disease patients and association with disease outcomes in the United States Medicaid population, 2010–2019
    Ryan A. Jasper, Po‐Hung Chen, Reeha Patel, Shelly Joseph, Steven D. Miller, Susan Hutfless
    JGH Open.2023; 7(4): 291.     CrossRef
  • Inflammatory Bowel Disease: Pathophysiology, Treatment, and Disease Modeling
    Jiryeon Jang, Sehoon Jeong
    BioChip Journal.2023; 17(4): 403.     CrossRef
  • High-Dimensional DNA Methylation Mediates the Effect of Smoking on Crohn’s Disease
    Tingting Wang, Pingtian Xia, Ping Su
    Frontiers in Genetics.2022;[Epub]     CrossRef
  • Inflammatory bowel disease in Korea: epidemiology and pathophysiology
    Jung Won Lee, Chang Soo Eun
    The Korean Journal of Internal Medicine.2022; 37(5): 885.     CrossRef
  • Clinical profile, course and outcomes of adults with inflammatory bowel disease over a decade: a single center experience
    Reham Saleh Aljohani, Ali Alaklabi, Yumna Mohammed Alsitary, Majd Abdulrahman bin Khunayn, Shahd Omar Hijazi, Rema Ibraheem Alshagary, Rajkumar Rajendram
    Annals of Saudi Medicine.2022; 42(6): 397.     CrossRef
  • 9,297 View
  • 202 Download
  • 18 Web of Science
  • 17 Crossref
Close layer
IBD
Management of inflammatory bowel disease in older persons: evolving paradigms
Saurabh Kedia, Jimmy K. Limdi, Vineet Ahuja
Intest Res 2018;16(2):194-208.   Published online April 30, 2018
DOI: https://doi.org/10.5217/ir.2018.16.2.194
AbstractAbstract PDFPubReaderePub

The incidence and prevalence of inflammatory bowel disease (IBD) is increasing, and considering the aging population, this number is set to increase further in the future. The clinical features and natural history of elderly-onset IBD have many similarities with those of IBD in younger patients, but with significant differences including a broader differential diagnosis. The relative lack of data specific to elderly patients with IBD, often stemming from their typical exclusion from clinical trials, has made clinical decision-making somewhat challenging. Treatment decisions in elderly patients with IBD must take into account age-specific concerns such as comorbidities, locomotor and cognitive function, and polypharmacy, to set realistic treatment targets in order to enable personalized treatment and minimize harm. Notwithstanding paucity of clinical data, recent studies have provided valuable insights, which, taken together with information gleaned from previous studies, can broaden our understanding of IBD. These insights may contribute to the development of paradigms for the holistic and, when possible, evidence-based management of this potentially vulnerable population and are the focus of this review.

Citations

Citations to this article as recorded by  
  • Older Adults with Inflammatory Bowel Disease Epidemiology in the United States: 2000–2021
    Pojsakorn Danpanichkul, Yanfang Pang, Chawinthorn Vuthithammee, Disatorn Dejvajara, Priyata Dutta, Passisd Laoveeravat, Omar Al Ta’ani, Agnes HY. Ho, Chun Wei Pan, Nicole Shu Ying Tang, Kanokphong Suparan, Rashid N. Lui, Donghee Kim, Siew C. Ng, Gursimran
    Digestive Diseases and Sciences.2025;[Epub]     CrossRef
  • Prevalence of metabolic syndrome in patients with inflammatory bowel disease: a meta-analysis on a global scale
    Khushbu Viresh Janani, Parsa Saberian, Hardik B. Patel, Narsimha Rao Keetha, Ardalan Etemadzadeh, Anya Patel, Seyyed Mohammad Hashemi, Ehsan Amini-Salehi, Anoop Gurram
    Journal of Health, Population and Nutrition.2025;[Epub]     CrossRef
  • Fatigue, sarcopenia, and frailty in older adults with inflammatory bowel disease
    Federica BELLONE, Alberto SARDELLA, Marco MUSCIANISI, Giorgio BASILE
    Minerva Gastroenterology.2024;[Epub]     CrossRef
  • Histology of IBD and related colitides in the elderly
    Giuseppe LEONCINI, Luca REGGIANI-BONETTI, Gloria SIMONCELLI, Vincenzo VILLANACCI
    Minerva Gastroenterology.2024;[Epub]     CrossRef
  • Age over sex: evaluating gut microbiota differences in healthy Chinese populations
    Jiacheng Wu, Hexiao Shen, Yongling Lv, Jing He, Xiaotian Xie, Zhiyue Xu, Pengcheng Yang, Wei Qian, Tao Bai, Xiaohua Hou
    Frontiers in Microbiology.2024;[Epub]     CrossRef
  • Clinical outcomes amongst elderly patients with inflammatory bowel disease
    Vithoosharan Sivanathan, Chamara Basnayake, William Connell, Emily Wright, John Nik Ding, Ola Niewadomski, Annalise Stanley, Amy Wilson‐O'Brien, Stephanie Fry, Tamie Samyue, Mark Lust, Emma Flanagan, Alexander J. V. Thompson, Michael A. Kamm
    Internal Medicine Journal.2023; 53(10): 1866.     CrossRef
  • Non-neoplastic disorders in an aging gut: concise review
    Saurabh Dawra, Pradeep Behl, Sharad Srivastava, Manish Manrai, Alok Chandra, Anupam Kumar, Ankit Kumar, Manveer Singh Tevatia
    The Egyptian Journal of Internal Medicine.2023;[Epub]     CrossRef
  • Enfermedad Inflamatoria Intestinal en el adulto mayor: Características clínicas y manejo en un hospital de referencia
    Juan Eloy Paredes Méndez, Sonia Irene Pérez Junes, Henry Tomás Vargas Marcacuzco, Edith Melissa Villafuerte Méndez
    Revista de Gastroenterología del Perú.2023; 43(1): 13.     CrossRef
  • Clinical spectrum of elderly-onset inflammatory bowel disease in India
    Yogesh Kumar Gupta, Arshdeep Singh, Vikram Narang, Vandana Midha, Ramit Mahajan, Varun Mehta, Dharmatma Singh, Namita Bansal, Madeline Vithya Barnaba Durairaj, Amit Kumar Dutta, Ajit Sood
    Intestinal Research.2023; 21(2): 216.     CrossRef
  • A new face of old cells: An overview about the role of senescence and telomeres in inflammatory bowel diseases
    Michał Sienkiewicz, Kamila Sroka, Agata Binienda, Diana Jurk, Jakub Fichna
    Ageing Research Reviews.2023; 91: 102083.     CrossRef
  • Representation and reporting of diverse groups in randomised controlled trials of pharmacological agents in inflammatory bowel disease: a systematic review
    Mythili Menon Pathiyil, Anuraag Jena, Arvind Kumar Venkataramana Raju, Tina Aswani Omprakash, Vishal Sharma, Shaji Sebastian
    The Lancet Gastroenterology & Hepatology.2023; 8(12): 1143.     CrossRef
  • Relation of geriatric nutritional risk index with clinical risks in elderly‐onset ulcerative colitis
    Masaaki Higashiyama, Shunsuke Komoto, Yasuo Suzuki, Mamoru Watanabe, Toshifumi Hibi, Soichiro Miura, Ryota Hokari
    Journal of Gastroenterology and Hepatology.2021; 36(1): 163.     CrossRef
  • Atopic dermatitis does not increase the risk of inflammatory bowel disease: A nationwide cohort study
    Yu‐Ching Weng, Chao‐Kuei Juan, Hsiu J. Ho, Yi‐Ling Chang, Chun‐Ying Wu, Yi‐Ju Chen
    The Journal of Dermatology.2021; 48(2): 168.     CrossRef
  • Common Diarrheal Illnesses in the Elderly
    Enad Dawod, Carl V. Crawford
    Clinics in Geriatric Medicine.2021; 37(1): 103.     CrossRef
  • Inflammatory Bowel Disease: Managing Complex Patients
    Paula Miksa, Shane Ryan Apperley
    Physician Assistant Clinics.2021; 6(4): 655.     CrossRef
  • The dietary practices and beliefs of people living with older-onset inflammatory bowel disease
    Benjamin Crooks, Ravi Misra, Naila Arebi, Klaartje Kok, Matthew J. Brookes, John McLaughlin, Jimmy K. Limdi
    European Journal of Gastroenterology & Hepatology.2021; 33(1S): e442.     CrossRef
  • Inflammatory bowel disease (IBD) position statement of the Italian Society of Colorectal Surgery (SICCR): general principles of IBD management
    G. Pellino, D. S. Keller, G. M. Sampietro, V. Annese, M. Carvello, V. Celentano, C. Coco, F. Colombo, N. Cracco, F. Di Candido, M. Franceschi, S. Laureti, G. Mattioli, L. Pio, G. Sciaudone, G. Sica, V. Villanacci, R. Zinicola, S. Leone, S. Danese, A. Spin
    Techniques in Coloproctology.2020; 24(2): 105.     CrossRef
  • Case 8-2020: An 89-Year-Old Man with Recurrent Abdominal Pain and Bloody Stools
    Richard C. Cabot, Eric S. Rosenberg, Virginia M. Pierce, David M. Dudzinski, Meridale V. Baggett, Dennis C. Sgroi, Jo-Anne O. Shepard, Kathy M. Tran, Emily K. McDonald, Tara Corpuz, Hacho B. Bohossian, Emily W. Lopes, Lauren A. Roller, Ashwin N. Ananthakr
    New England Journal of Medicine.2020; 382(11): 1042.     CrossRef
  • Elderly-onset vs adult-onset ulcerative colitis: a different natural history?
    Irene Zammarchi, Francesco Lanzarotto, Rosanna Cannatelli, Francesca Munari, Federica Benini, Alessandro Pozzi, Alberto Lanzini, Chiara Ricci
    BMC Gastroenterology.2020;[Epub]     CrossRef
  • Association between inflammatory bowel disease and bullous pemphigoid: a population-based case–control study
    Yi-Ju Chen, Chao-Kuei Juan, Yun-Ting Chang, Chun-Ying Wu, Hsiu J. Ho, Hsiao-Ching Tseng
    Scientific Reports.2020;[Epub]     CrossRef
  • Dietary Support in Elderly Patients with Inflammatory Bowel Disease
    Piotr Eder, Alina Niezgódka, Iwona Krela-Kaźmierczak, Kamila Stawczyk-Eder, Estera Banasik, Agnieszka Dobrowolska
    Nutrients.2019; 11(6): 1421.     CrossRef
  • Exploring the therapeutic potential of sodium benzoate in acetic acid-induced ulcerative colitis in rats
    Deepali Walia, Gurpreet Kaur, Amteshwar Singh Jaggi, Anjana Bali
    Journal of Basic and Clinical Physiology and Pharmacology.2019;[Epub]     CrossRef
  • 9,055 View
  • 186 Download
  • 23 Web of Science
  • 22 Crossref
Close layer
Recent Updates on the Treatment of Constipation
Han Seung Ryu, Suck Chei Choi
Intest Res 2015;13(4):297-305.   Published online October 15, 2015
DOI: https://doi.org/10.5217/ir.2015.13.4.297
AbstractAbstract PDFPubReaderePub

The treatment of constipation aims to regulate the frequency and quantity of stool in order to promote successful defecation. Numerous studies on pharmacologic treatments and non-pharmacologic therapies for constipation have attempted to overcome limitations such as temporary and insufficient efficacy. Conventional laxatives have less adverse effects and are inexpensive, but often have limited efficacy. Recently developed enterokinetic agents and intestinal secretagogues have received attention owing to their high efficacies and low incidences of adverse events. Studies on biofeedback and surgical treatment have focused on improving symptoms as well as quality of life for patients with refractory constipation.

Citations

Citations to this article as recorded by  
  • EFFICACY AND SAFETY OF INTESTINAL SECRETAGOGUES FOR CHRONIC CONSTIPATION: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Juan Sebastian LASA, María Josefina ALTAMIRANO, Luis Florez BRACHO, Silvina PAZ, Ignacio ZUBIAURRE
    Arquivos de Gastroenterologia.2018; 55(suppl 1): 2.     CrossRef
  • Relation of Enteric α-Synuclein to Gastrointestinal Dysfunction in Patients With Parkinson's Disease and in Neurologically Intact Subjects
    Hyo Jeong Lee, Kee Wook Jung, Sun Ju Chung, Seung-Mo Hong, Juyeon Kim, Jeong Hoon Lee, Sung Wook Hwang, Ho-Sung Ryu, Mi Jung Kim, Ho-Su Lee, Myeongsook Seo, Sang Hyoung Park, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Jaewon Choe, Hwoon-Yong Jung, Suk
    Journal of Neurogastroenterology and Motility.2018; 24(3): 469.     CrossRef
  • Clinical efficacy of the traditional Chinese herbal formula, (Tong Bian Decoction) on laxative dependence constipation in elderly persons: A randomized, multicenter, controlled trial
    Yinzi Yue, Xiaopeng Wang, Huiju Yang, Mingming Sun, Shujun Chen, Haihua Qian, Tianshu Xu, Shuai Yan
    European Journal of Integrative Medicine.2018; 24: 23.     CrossRef
  • 5,926 View
  • 66 Download
  • 4 Web of Science
  • 3 Crossref
Close layer

Intest Res : Intestinal Research
Close layer
TOP